Mukka Proteins

33.98
-0.84
(-2.41%)
Market Cap
1,019.40 Cr
EPS
3.10
PE Ratio
17.10
Dividend Yield
0.00 %
52 Week High
56.56
52 Week low
30.00
PB Ratio
2.56
Debt to Equity
1.15
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Mukka Proteins Secures Purchase Orders Worth 442.8 Million Rupees6 days ago
Mukka Proteins has received purchase orders totaling 442.8 million rupees for the supply of fish meal and oil. This significant order demonstrates strong demand for the company's products and potentially indicates positive business performance.
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
736.10 14,152.40 33.99 9,601.90 1.27 359 32.29 49.31
819.95 11,171.50 23.21 5,505.20 6.30 394 69.03 68.93
33.98 1,019.40 17.10 1,396.10 17.93 74 121.49 44.35
1,949.00 623.70 8.50 1,687.50 4.46 18 1,809.09 44.37
231.00 124.70 41.10 290.60 -6.14 3 113.21 44.28
50.00 84.90 72.46 147.10 -6.31 1 50.00 53.03
17.07 23.10 16.36 50.40 0.60 1 900.00 40.32
Growth Rate
Revenue Growth
17.93 %
Net Income Growth
56.42 %
Cash Flow Change
-167.02 %
ROE
-40.33 %
ROCE
-43.94 %
EBITDA Margin (Avg.)
11.22 %

Quarterly Financial Results

Quarterly Financials
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
397
409
269
331
510
255
170
149
303
Expenses
362
378
260
294
498
225
159
140
262
EBITDA
34
31
9
37
12
30
11
9
41
Operating Profit %
8 %
8 %
2 %
9 %
1 %
10 %
5 %
4 %
12 %
Depreciation
3
3
3
3
3
3
3
4
4
Interest
4
7
6
6
6
7
8
9
11
Profit Before Tax
33
33
8
35
18
27
6
1
33
Tax
6
11
4
6
5
-2
0
-0
6
Net Profit
27
22
4
29
12
29
5
2
27
EPS in ₹
1.03
0.99
0.16
1.29
0.48
1.20
0.14
0.07
0.88

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
Total Assets
201
293
355
392
575
941
Fixed Assets
49
78
79
83
85
85
Current Assets
142
206
257
286
464
817
Capital Work in Progress
0
2
4
0
0
0
Investments
8
4
12
21
21
31
Other Assets
144
209
260
289
469
825
Total Liabilities
201
293
355
392
575
941
Current Liabilities
137
218
272
274
403
521
Non Current Liabilities
20
18
13
15
17
12
Total Equity
44
58
70
103
156
408
Reserve & Surplus
39
51
61
76
126
366
Share Capital
6
6
6
22
22
30

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
Net Cash Flow
-9
1
2
8
15
65
Investing Activities
-23
-28
-14
-12
-3
-51
Operating Activities
-20
-25
2
5
-56
-150
Financing Activities
34
54
14
15
75
266

Share Holding

% Holding
Jun 2023
Dec 2023
Feb 2024
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
85.22 %
73.33 %
100.00 %
73.33 %
73.33 %
73.33 %
73.33 %
FIIs
0.00 %
0.00 %
0.00 %
6.46 %
5.08 %
2.82 %
2.63 %
DIIs
0.00 %
4.59 %
0.00 %
2.00 %
2.50 %
2.00 %
1.98 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
12.70 %
0.00 %
17.38 %
17.54 %
19.32 %
19.43 %
Others
14.78 %
9.38 %
0.00 %
0.83 %
1.56 %
2.53 %
2.62 %
No of Share Holders
8
54,061
8
54,061
1,12,093
1,44,549
1,46,062

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
6 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 16, 2025, 11:44
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Feb 14, 2025, 20:16
Statement Of Deviation(S) Or Variation(S) For The Quarter Ended 31St December 2024.
Feb 14, 2025, 20:06
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Feb 14, 2025, 19:12
Announcement under Regulation 30 (LODR)-Preferential Issue
Feb 14, 2025, 19:01
The Board Of Directors Have Approved Issuance Of Corporate Guarantee To Ocean Proteins Private Limited Associate Company.
Feb 14, 2025, 18:56
Integrated Filing (Financial)
Feb 14, 2025, 18:47
Board Meeting Outcome for Financial Results For The Quarter And Nine Months Period Ended 31St December 2024.
Feb 14, 2025, 18:36
Financial Results For The Quarter And Nine Months Period Ended 31St December 2024.
Feb 14, 2025, 18:34
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Period Ended 31St December 2024.
Feb 07, 2025, 13:18
Intimation Of Receipt Of In-Principal Approval From National Stock Exchange Of India Limited And BSE Limited For Issue Of Equity Shares To Promoter And Non-Promoter Category On A Preferential Basis.
Feb 04, 2025, 14:19
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 16, 2025, 12:46
Announcement under Regulation 30 (LODR)-Credit Rating
Jan 15, 2025, 12:54
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
Jan 08, 2025, 11:09
Closure of Trading Window
Dec 28, 2024, 11:15
Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
Dec 17, 2024, 16:57
Shareholder Meeting / Postal Ballot-Scrutinizers Report
Nov 18, 2024, 17:49
Shareholder Meeting / Postal Ballot-Outcome of EGM
Nov 16, 2024, 17:00
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 16, 2024, 10:42
Statement Of Deviation & Variation
Nov 14, 2024, 22:09
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Nov 14, 2024, 22:06
Amendment To The Company'S Code Of Conduct For Regulating, Monitoring And Reporting Of Trading By Insiders
Nov 14, 2024, 19:08
Board Meeting Outcome for Outcome Of Board Meeting.
Nov 14, 2024, 18:34
Outcome Of Board Meeting.
Nov 14, 2024, 18:31
Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended 30Th September 2024.
Nov 08, 2024, 17:18
Announcement under Regulation 30 (LODR)-Newspaper Publication
Oct 24, 2024, 11:50
Notice Of 01/2024 Extra-Ordinary General Meeting (EGM) Of The Company.
Oct 23, 2024, 17:27
Board Meeting Outcome for Revised Outcome Of Board Meeting Held On 21St October 2024.
Oct 22, 2024, 16:35
Announcement under Regulation 30 (LODR)-Newspaper Publication
Oct 22, 2024, 12:47
Board Comments On Fine Levied By The Exchanges.
Oct 22, 2024, 12:29
Approval For Increase In The Authorised Share Capital Of The Company.
Oct 21, 2024, 17:54
Announcement under Regulation 30 (LODR)-Preferential Issue
Oct 21, 2024, 17:09
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Oct 21, 2024, 17:07
Board Meeting Outcome for Outcome Of Board Meeting.
Oct 21, 2024, 16:59
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday, 21St October 2024.
Oct 14, 2024, 18:03
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 10, 2024, 17:02
Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
Sep 30, 2024, 15:50
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Sep 27, 2024, 18:29
Closure of Trading Window
Sep 27, 2024, 18:10
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sep 27, 2024, 17:48
Announcement under Regulation 30 (LODR)-Change in Management
Sep 26, 2024, 19:13
Shareholder Meeting / Postal Ballot-Outcome of AGM
Sep 26, 2024, 18:43
Announcement under Regulation 30 (LODR)-Newspaper Publication
Sep 04, 2024, 12:23
Reg. 34 (1) Annual Report.
Sep 03, 2024, 17:34
Notice Of 14Th Annual General Meeting (AGM) Of The Company.
Sep 03, 2024, 17:21
Announcement under Regulation 30 (LODR)-Newspaper Publication
Aug 27, 2024, 13:07
Board Comments On Fine Levied By The Exchange
Aug 26, 2024, 17:58
Disclosure Under Regulation 30 Of The SEBI Listing Regulations.
Aug 22, 2024, 18:16
Intimation Of The Order Received From Income Tax Appellate Tribunal, C Bench: Bangalore With Respect To Mr. Kalandan Mohammed Haris, Managing Director And CEO.
Aug 14, 2024, 17:58

Company Filings to Exchanges

Technical Indicators

RSI(14)
Neutral
44.35
ATR(14)
Less Volatile
1.71
STOCH(9,6)
Neutral
41.02
STOCH RSI(14)
Overbought
91.33
MACD(12,26)
Bullish
0.20
ADX(14)
Weak Trend
19.14
UO(9)
Bearish
38.09
ROC(12)
Uptrend But Slowing Down
0.41
WillR(14)
Neutral
-61.46